Department of Anesthesiology, State University of New York, Downstate Medical Center, Brooklyn, New York 11203, USA.
Fertil Steril. 2010 Jun;94(1):276-82. doi: 10.1016/j.fertnstert.2009.02.024. Epub 2009 Mar 26.
To study the distribution of ionized and total magnesium (Mg) in serum and cerebral spinal fluid (CSF) in preeclamptic women receiving MgSO(4) and how this treatment affects the ionized calcium (Ca(2+)) and ionized Ca:Mg ratios compared with healthy nonpregnant women and pregnant control women (HP).
Controlled clinical study.
An academic medical center.
PATIENT(S): African-American women older than 20 and less than 35 years. The pregnant preeclamptic study and pregnant control groups each consisted of 16 women; the nonpregnant group consisted of 10 subjects.
INTERVENTION(S): The preeclamptic women received a 6-g bolus of MgSO(4) IV started at least 4.5 hours before delivery during 15-20 minutes, then 2 g/h baseline.
MAIN OUTCOME MEASURE(S): The CSF and serum levels of Ca(2+) and Mg(2+) and total Mg were measured in all three groups of women. The Ca(2+):Mg(2+) ratios were determined. Physiologic monitoring was done and recorded every 4 hours where appropriate. Bloods were drawn every 6 hours for complete blood count, metabolic panel, lactate dehydrogenase, uric acid, and electrolytes. Serum pH, total Mg, Apgar scores, and general health of the infants born to preeclamptic mothers given MgSO(4) were followed.
RESULT(S): The HP showed a reduction in mean serum ionized and total Mg, increase in ionized Ca, and a large increase in Ca(2+):Mg(2+) ratios compared with healthy nonpregnant women. Although the CSF ionized and total Mg and Ca(2+):Mg(2+) ratios were not altered with MgSO(4) treatment in the preeclamptic women receiving MgSO(4), the mean serum Mg values increased 3-fold. All infants were full-term, regardless of MgSO(4) treatment, and normal with respect to birth weight, Apgar scores, blood pH, total Mg, and neurologic scores.
CONCLUSION(S): The data indicate that there is a direct relationship between the serum and CSF Ca(2+):Mg(2+) ratios in HP and this ratio may be crucial in preventing vascular and neurologic complications in preeclampsia-eclampsia.
研究接受硫酸镁治疗的子痫前期妇女血清和脑脊液中离子化和总镁(Mg)的分布情况,以及这种治疗如何影响离子化钙(Ca(2+))和离子化 Ca:Mg 比值,与健康非妊娠妇女和妊娠对照组(HP)相比。
对照临床研究。
学术医疗中心。
年龄在 20 岁以上且小于 35 岁的非裔美国妇女。子痫前期研究组和妊娠对照组各有 16 名妇女;非妊娠组有 10 名受试者。
子痫前期妇女在分娩前至少 4.5 小时开始接受 6g 硫酸镁静脉推注,持续 15-20 分钟,然后以 2g/h 为基础。
对三组妇女的 CSF 和血清 Ca(2+)和 Mg(2+)及总 Mg 水平进行测量。确定 Ca(2+):Mg(2+)比值。进行生理监测并在适当情况下每 4 小时记录一次。每 6 小时抽取血液进行全血细胞计数、代谢谱、乳酸脱氢酶、尿酸和电解质检测。监测血清 pH、总 Mg、Apgar 评分以及接受硫酸镁治疗的子痫前期母亲所生婴儿的一般健康状况。
与健康非妊娠妇女相比,HP 组血清离子化和总 Mg 降低,离子化 Ca 增加,Ca(2+):Mg(2+)比值显著增加。尽管接受硫酸镁治疗的子痫前期妇女的 CSF 离子化和总 Mg 及 Ca(2+):Mg(2+)比值未发生变化,但血清 Mg 值增加了 3 倍。所有婴儿均为足月产,与硫酸镁治疗无关,出生体重、Apgar 评分、血 pH、总 Mg 和神经评分均正常。
数据表明,HP 中血清和 CSF Ca(2+):Mg(2+)比值之间存在直接关系,该比值可能是预防子痫前期-子痫血管和神经并发症的关键。